This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human RAGE DuoSet ELISA
catalog :
DY1145
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 26
Reference
Kanikowska D, Kanikowska A, Strojny Z, Kawka E, Zawada A, Rutkowski R, et al. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition. Cytokine. 2024;180:156665 pubmed publisher
Tsoporis J, Triantafyllis A, Kalogeropoulos A, Izhar S, Rigopoulos A, Rallidis L, et al. Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia. Biomolecules. 2023;14: pubmed publisher
Xiong Y, Wang B, Jiao J, Tang M, Li K, Jiang R, et al. Expression and clinical association of MFG-E8 and TAM receptors in diabetic patients with different stages of microvascular complication: An experimental study. Medicine (Baltimore). 2023;102:e35788 pubmed publisher
Warren K, Beck E, Callahan S, Helms M, Middleton E, Maddock S, et al. Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype. Respir Res. 2023;24:162 pubmed publisher
Helleputte S, Calders P, Rodenbach A, Marlier J, Verroken C, De Backer T, et al. Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes. Cardiovasc Diabetol. 2022;21:277 pubmed publisher
Sabbatinelli J, Castiglione S, Macr xec F, Giuliani A, Ramini D, Vinci M, et al. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study. Cardiovasc Diabetol. 2022;21:95 pubmed publisher
Lee K, Park K, Kim Y, Cho I, Kim T. Prediction of emergency cerclage outcomes in women with cervical insufficiency: The role of inflammatory, angiogenic, and extracellular matrix-related proteins in amniotic fluid. PLoS ONE. 2022;17:e0268291 pubmed publisher
Villar J, Herrán Monge R, Gonzalez Higueras E, Prieto González M, Ambrós A, Rodríguez Pérez A, et al. Clinical and biological markers for predicting ARDS and outcome in septic patients. Sci Rep. 2021;11:22702 pubmed publisher
Scavello F, Zeni F, Milano G, Macrì F, Castiglione S, Zuccolo E, et al. Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis. Int J Biol Sci. 2021;17:2399-2416 pubmed publisher
Pratte K, Curtis J, Kechris K, Couper D, Cho M, Silverman E, et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir Res. 2021;22:127 pubmed publisher
Dozio E, Vettoretti S, Caldiroli L, Nerini Molteni S, Tacchini L, Ambrogi F, et al. Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD. Biomedicines. 2020;8: pubmed publisher
Dozio E, Sitzia C, Pistelli L, Cardani R, Rigolini R, Ranucci M, et al. Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers. J Clin Med. 2020;9: pubmed publisher
Tsoporis J, Hatziagelaki E, Gupta S, Izhar S, Salpeas V, Tsiavou A, et al. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes. Molecules. 2020;25: pubmed publisher
Melin E, Dereke J, Hillman M. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: . Lipids Health Dis. 2020;19:223 pubmed publisher
Fotheringham A, Bagger J, Borg D, McCarthy D, Holst J, Vilsbøll T, et al. Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes. Nutrients. 2020;12: pubmed publisher
Dozio E, Vianello E, Sitzia C, Ambrogi F, Benedini S, Gorini S, et al. Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health. J Clin Med. 2020;9: pubmed publisher
Galliera E, Massaccesi L, de Benedettis E, Longhi E, De Toma D, Corsi Romanelli M, et al. Longitudinal evaluation of Wnt inhibitors and comparison with others serum osteoimmunological biomarkers in osteolytic bone metastasis. J Leukoc Biol. 2020;108:697-704 pubmed publisher
Scavello F, Zeni F, Tedesco C, Mensà E, Veglia F, Procopio A, et al. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging. Aging (Albany NY). 2019;11:1648-1663 pubmed publisher
Braley A, Kwak T, Jules J, Harja E, Landgraf R, Hudson B. Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function. J Biol Chem. 2016;291:12057-73 pubmed publisher
Moser B, Janik S, Schiefer A, Müllauer L, Bekos C, Scharrer A, et al. Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. PLoS ONE. 2014;9:e94118 pubmed publisher
Palombo C, Kozakova M, Morizzo C, Gnesi L, Barsotti M, Spontoni P, et al. Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol. 2011;10:88 pubmed publisher
Basta G, Corciu A, Vianello A, Del Turco S, Foffa I, Navarra T, et al. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis. 2010;210:614-8 pubmed publisher
Basta G, Castagnini M, Del Turco S, Epistolato M, Righini P, Sangiorgi G, et al. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis. Eur J Clin Invest. 2009;39:1065-72 pubmed publisher
Hsu H, Wittemann S, Schneider E, Weiss M, Joos T. Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases. Med Eng Phys. 2008;30:976-83 pubmed publisher
Determann R, Wolthuis E, Choi G, Bresser P, Bernard A, Lutter R, et al. Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;294:L344-50 pubmed
Mallidis C, Agbaje I, Rogers D, Glenn J, McCullough S, Atkinson A, et al. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod. 2007;22:2169-77 pubmed
product information
master code :
DY1145
SKU :
DY1145
product name :
Human RAGE DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human RAGE DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human AGER.
target :
RAGE/AGER
category :
ELISAs
species :
Human
gene symbol :
AGER
kit type :
Solid Phase Sandwich ELISA
elisaRange :
62.50 - 4000 pg/mL
top caption :
Human RAGE ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
advanced glycosylation end product-specific receptor, AGER, RAGE isoform delta, RAGE isoform sRAGE-delta, Receptor for advanced glycosylation end products, receptor for advanced glycosylation end-products, SCARJ1
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.